Obinutuzumab (anti-CD20)
Catalogue Number: A2023-SEL
| Manufacturer: | Selleck Chemicals |
| Type: | Recombinant Monoclonal |
| Shipping Condition: | Dry Ice |
| Unit(s): | 5 mg, 1 mg, 25 x 1 mg |
Description
Description: Obinutuzumab (anti-CD20) (Gazyva, GA101, Gazyvaro, Afutuzumab) is a novel, type II, glycoengineered, humanized anti-CD20 monoclonal antibody that has been developed for lymphocytic leukemia and lymphoma of B-cell origin. MW : 146.1 kD.
Additional Text
CAS Number
949142-50-1
A2023 MSDS
SUPPORT
outstanding technical support
PRODUCT
we offer a full product guarantee
DELIVERY
we offer free delivery to UK universities and non profit organisations